Vectibix(R) In Combination With Chemotherapy Significantly Improves Progression-Free Survival In Second-Line Metastatic Colorectal Cancer
Links shared publicly online about this topic.
- 1,728total visits
Vectibix(R) In Combination With Chemotherapy Significantly Improves Progression-Free Survival In Second-Line Metastatic Colorectal Cancer
Amgen (Nasdaq: AMGN) announced detailed results from the Phase 3 '181' trial evaluating Vectibix((R)) (panitumumab) in combination with FOLFIRI (an irinotecan based chemotherapy), as a second-lin
View full resource at medicalnewstoday.com
Tags: Cancer, Chemotherapy, Rectal Cancer, Colon Cancer, Colorectal Cancer Medication, Camptosar, Vectibix, Amgen
Most Recently Shared on September 23, 2009 at 12:17 pm By:
Vectibix(R) In Combination With Chemotherapy Significantly Improves Progression-Free Survival In Second-Line Met.. http://bit.ly/1OcVFd
Vectibix(R) In Combination With Chemotherapy Significantly Improves Progression-Free Survival In First-Line Metastatic Colorectal Cancer
medicalnewstoday.com — “Amgen (Nasdaq: AMGN) announced detailed results from the Phase 3 '203' trial evaluating Vectibix(R) (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as the” View full resource at medicalnewstoday.com
Most Recently Shared on September 25, 2009 at 12:54 pm By:
MNT Clinical Trials Health News
Vectibix(R) In Combination With Chemotherapy Significantly Improves Progression-Free Survival In First-Line Met.. http://bit.ly/12AhEO
Advertisement
